GPX4 Gene: Glutathione Peroxidase 4 - Ferroptosis Regulator and Disease Implications

Comprehensive resource on GPX4 (Glutathione Peroxidase 4), covering gene structure, function, expression, mutations, and clinical significance in cancer, neurodegeneration, and rare genetic disorders.

Gene Information Card

Symbol GPX4
Full Name Glutathione Peroxidase 4
Gene Type Protein coding
Chromosomal Location 19p13.3
NCBI Gene ID 2879 ncbi.nlm.nih.gov/gene/2879
Ensembl ID ENSG00000167468
UniProt ID P36969
OMIM ID 138320
HGNC ID 4556
Aliases PHGPx, snGPx, mtPHGPx, GPx-4, GSHPx-4

Description

The GPX4 gene encodes glutathione peroxidase 4, a selenium-dependent phospholipid hydroperoxidase that reduces lipid hydroperoxides to their corresponding alcohols, protecting cells against oxidative membrane damage. It is a critical inhibitor of ferroptosis, a form of regulated cell death driven by iron-dependent lipid peroxidation. GPX4 is expressed as multiple isoforms (mitochondrial, cytosolic, and nuclear) with distinct subcellular localizations and functions. Beyond its antioxidant role, GPX4 is involved in spermatogenesis, embryonic development, and immune regulation. Mutations in GPX4 are associated with spondylometaphyseal dysplasia (SMD) and Sedaghatian-type, while dysregulated expression is linked to various cancers and neurodegenerative diseases.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Spondylometaphyseal dysplasia, Sedaghatian type Biallelic loss-of-function mutations in GPX4 lead to impaired lipid peroxide detoxification, causing abnormal skeletal development and early lethality. OMIM #250220; ClinVar; PMID: 24448817
Colorectal cancer GPX4 overexpression promotes tumor cell survival by suppressing ferroptosis, contributing to chemoresistance and poor prognosis. COSMIC; PMID: 31209336
Hepatocellular carcinoma Elevated GPX4 expression correlates with aggressive tumor features and resistance to sorafenib via ferroptosis inhibition. PMID: 31164344
Neurodegenerative diseases (e.g., Alzheimer's, Parkinson's) GPX4 deficiency in neurons leads to lipid peroxidation and ferroptotic cell death, implicated in neurodegeneration. PMID: 30559424
Ischemia-reperfusion injury Reduced GPX4 activity increases ferroptosis in affected tissues, exacerbating injury. PMID: 31004006

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 25.1 High
Kidney 18.3 High
Liver 15.7 High
Heart 12.4 Medium
Brain 10.2 Medium
Lung 8.9 Medium
Spleen 6.5 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver cancer) 20.5 High expression; sensitive to ferroptosis inducers
A549 (lung cancer) 15.3 Moderate; GPX4 inhibition suppresses growth
MCF7 (breast cancer) 12.8 Moderate; associated with tamoxifen resistance
K562 (leukemia) 9.4 Low; ferroptosis induction effective
HEK293 (embryonic kidney) 18.1 High; used for functional studies
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.587T>C (p.Leu196Pro) Missense Rare (found in SMD patients) Loss of function; disrupts enzyme activity and protein stability
c.586C>T (p.Arg196Trp) Missense Rare (found in SMD patients) Loss of function; impaired lipid peroxide reduction
c.3G>A (p.Met1?) Start codon loss Rare Loss of function; abrogates translation
c.364_365del (p.Leu122Valfs*2) Frameshift Rare Loss of function; truncated protein
c.458C>T (p.Pro153Leu) Missense Somatic (cancer) Potential gain of function; increased stability, enhanced ferroptosis resistance
Mutation functional classification

Loss of Function (LOF)

Most GPX4 mutations are loss-of-function, leading to reduced enzymatic activity and increased susceptibility to ferroptosis. These are typically associated with rare genetic disorders like Sedaghatian-type spondylometaphyseal dysplasia.

Gain of Function (GOF)

Somatic missense mutations in cancer may confer gain-of-function by increasing protein stability or activity, promoting tumor survival and therapy resistance.

Dominant Negative (DN)

No clear dominant-negative mutations have been reported; GPX4 is a monomeric enzyme, and most pathogenic variants are recessive.

Pathways

Ferroptosis (hsa04216)
Glutathione metabolism (hsa00480)
Metabolism of lipids (Reactome: R-HSA-556833)
Selenium micronutrient network (Reactome: R-HSA-2408557)
Oxidative stress response (Reactome: R-HSA-2262752)

Protein Summary

GPX4 is a 197-amino acid selenoprotein (UniProt P36969) that exists in three isoforms: mitochondrial (mtPHGPx), cytosolic (cPHGPx), and nuclear (snPHGPx). The protein contains a selenocysteine residue at position 73, which is essential for its catalytic activity. GPX4 reduces phospholipid hydroperoxides, cholesterol hydroperoxides, and thymine hydroperoxides, using glutathione as a cofactor. It is a key regulator of ferroptosis, preventing lipid peroxidation-induced cell death. Structurally, GPX4 is a monomeric enzyme with a thioredoxin-like fold. Its expression is regulated by Nrf2 and selenium availability. Post-translational modifications include phosphorylation and ubiquitination, affecting stability and activity. GPX4 also plays a role in sperm maturation and male fertility.

Related Products

Product name Cat.No. Species Gene ID
Gpx4 Knockout RAW 264.7 Cell Line EDJ-KZ27 Mouse 625249 Details Get a Quote
Gpx4 Knockout MODE-K Cell Line EDJ-KZ269 Mouse 2879 Details Get a Quote
GPX4 Knockout HEK293 Cell Line EDJ-KQ50315 Human 2879 Details Get a Quote
GPX4 Knockout HeLa Cell Line EDJ-KQ53417 Human 2879 Details Get a Quote
GPX4 Knockout A-549 Cell Line EDJ-KQ61892 Human 2879 Details Get a Quote
GPX4 Knockout HCT 116 Cell Line EDJ-KQ70373 Human 2879 Details Get a Quote
Displaying Records 1 To 6 Of 6 Records
Contact Us
*
*
*
*
How did you hear about us: